Dexmedetomidine and its increasing application in nonopioid detoxification.
Shailendra
S
Kapoor
D058647:Adrenergic alpha-2 Receptor Agonists / Q000008:administration & dosage*; D000768:Anesthesia, General; D018686:Anesthetics, Intravenous; D020927:Dexmedetomidine / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D015742:Propofol; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control*
D058647:Adrenergic alpha-2 Receptor Agonists; D018686:Anesthetics, Intravenous; D020927:Dexmedetomidine; D015742:Propofol